Overview of the 2014 Food and Drug Administration Circulatory System Devices Panel meeting regarding the Lutonix® drug coated balloon.

Escárcega, Ricardo O; Waksman, Ron

Escárcega, Ricardo O; Waksman, Ron.

Affiliation

Escárcega RO; Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC.
Waksman R; Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC. Electronic address: ron.waksman@medstar.net.

Cardiovasc Revasc Med ; 15(8): 402-7, 2014.

Article in En | MEDLINE | ID: mdl-25499024

Subject(s)

Angioplasty, Balloon/instrumentation; Peripheral Arterial Disease/surgery; Vascular Access Devices; Equipment Design; Humans; Treatment Outcome; United States; United States Food and Drug Administration; Vascular Access Devices/standards

Key words

Drug-coated balloon; Lutonix; US Food and Drug Administration

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Angioplasty, Balloon / Peripheral Arterial Disease / Vascular Access Devices Type of study: Clinical_trials / Guideline Limits: Humans Country/Region as subject: America do norte Language: En Journal: Cardiovasc Revasc Med Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2014 Document type: Article Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google